Compare LGHL & HLSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGHL | HLSQ |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | 20 |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 862.9K | 972.0K |
| IPO Year | 2020 | 2018 |
| Metric | LGHL | HLSQ |
|---|---|---|
| Price | $4.16 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 240.4K | ★ 699.7K |
| Earning Date | 04-30-2024 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 560.42 |
| EPS | N/A | ★ 3.56 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.12 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.38 |
| 52 Week High | $9.54 | $0.77 |
| Indicator | LGHL | HLSQ |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 5.48 |
| Support Level | $0.81 | $0.38 |
| Resistance Level | $5.89 | N/A |
| Average True Range (ATR) | 1.21 | 0.08 |
| MACD | -0.37 | -0.03 |
| Stochastic Oscillator | 6.78 | 10.23 |
Lion Group Holding Ltd provides an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, and Over-The-Counter (OTC) stock options trading business. It offers these services through its all-in-one Lion Brokers Pro app and a variety of other apps available on iOS, Android, PC, and Mac platforms. The company's clients are mostly well-educated and affluent Chinese investors residing both inside and outside the PRC (excluding the United States). Its operating segments are: OTC Stock option trading, which generates maximum revenue, CFD trading, TRS trading, and Other. Geographically, the company derives maximum revenue from Hong Kong.
Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.